When: Close above $412 on volume >5M shares

Then: Exit trim immediately—bearish thesis broken

SELL (underweight); Trim exposure into strength at $400-$410 zone; Wait for confirmed weekly close above $455 with volume to revisit longs; or await retest of $332-$352 zone for favorable risk-reward entry

• Revenue growth decelerated 360 basis points sequentially from 22.1% to 18.5%, a critical concern at 45x trailing earnings where multiple compression accelerates when growth bends
• 200 SMA at current levels represents key structural resistance reflecting institutional consensus cost basis; 'bear-market rally until proven otherwise' per technical report
• The $600+ to $332 drawdown (45% decline) WAS the multiple compression; current 32.5x forward earnings evaluated against 5% ten-year yield and 95% probability of zero Fed rate cuts in 2026
• 2027 ASP cut targets 75% of recurring revenue stream, creating near-term top-line headwind and margin compression risk on most profitable segment
• Risk-reward framing of 15.5% downside vs 27% upside is not probability-weighted; path to $332 requires continuation of existing trend while path to $500+ requires 5+ macro and fundamental catalysts
• $412 stop loss represents clear structural invalidation point; tight stops preserve capital and respect market's verdict
• Macro environment features elevated geopolitical risk, no Fed relief, and 8% recession probability vulnerable to upside if geopolitical tensions escalate
• The $332 to $352 zone offers favorable risk-reward for patient capital waiting for confirmation

→ vs aggressive: Treats growth LEVEL as the story rather than growth DIRECTION; the 360 bps sequential deceleration is the real signal, not the absolute 18.5% number

→ vs aggressive: Dismisses 200 SMA as 'lagging indicator'; this level reflects institutional consensus cost basis and positioning of largest capital pools, making it the single most important structural level to reclaim

→ vs aggressive: The drawdown from $600+ to $332 WAS the multiple compression; PEG of 1.78 looks expensive against prevailing 5% discount rate and zero Fed relief scenario

→ vs aggressive: Calls 2027 ASP cut a 'strategic volume capture play'; this ignores near-term margin compression on 75% of recurring revenue and treats management's pricing concession as bullish when it is a documented headwind

→ vs aggressive: Frames 15.5% downside vs 27% upside without probability-weighting; path to $500+ requires multiple macro and fundamental confirmations while path to $332 requires trend continuation

→ vs aggressive: Calls $412 stop 'too tight'; this reveals a risk philosophy of giving short theses more room rather than respecting disciplined structural invalidation points

Move to neutral weight (100% benchmark); trim existing underweight in the 400-410 zone back to neutral rather than holding at 75%; add on pullbacks to 371-373 with structural stop at 365, or chase a confirmed breakout above 402 on volume with tighter stops; reduce to underweight only if price fails at 365.

• Move to 100% benchmark weight (neutral) from 75% underweight, as momentum has shifted constructively (MACD bullish crossover, RSI recovery from 29 to 61, 4.87 million shares volume on breakout day)
• 45x trailing earnings is rich in 5% yield regime with 95% probability of zero rate cuts in 2026, but 32.5x forward P/E and 1.78 PEG ratio applied to 20% revenue growth and 30%+ earnings compounding is roughly fair
• Q2 2026 free cash flow hit record 948 million dollars; company has 5 billion in cash with zero debt
• Deceleration from 22.1% to 18.5% sequential growth on 11 billion revenue base is normal variance within the 17-22% compounding band, not a structural break
• 200 SMA at 13.5% above current price remains a structural anchor; move to HOLD with bullish bias from technical report, not SELL
• Risk-reward asymmetry (15.5% downside to 332 vs 27% upside to 500+) does not justify full conviction because paths are not equally probable
• 2027 ASP cut is a real headwind but magnitude and volume offset unknown until second half of 2027; warrants position size discount but not full exit
• Multiple has already compressed 35% from highs
• Prefer pullback entry to 371-373 zone (50 SMA and Bollinger middle band confluence) over chasing above 402 breakout level
• If price fails at 365, trader has permission to return to underweight, signaling momentum reversal has failed

→ vs aggressive: Dismissing the 200 SMA as intellectually lazy; the price is 13.5% below this most-watched structural level and has not tested it, so pretending the structural trend is up is how momentum traders get crushed when reversals fail

→ vs aggressive: Risk-reward asymmetry argument breaks down because it assumes equal probability between upside (27% to 500+) and downside (15.5% to 332) paths; the path to 500+ requires multiple things to go right while the path to 332 requires only the trend to continue

→ vs aggressive: 2027 ASP cut SELL thesis leans too heavily; this could be a strategic volume capture play if executed well over a multi-year horizon; market doesn't know which interpretation wins yet

→ vs conservative: 300 basis point deceleration framing is being weaponized beyond what the data supports; going from 22.1% to 18.5% on 11 billion revenue base is normal variance, not a structural break in a company compounding in the 17-22% band for four consecutive years

→ vs conservative: EPS more than doubled from 2022 to 2025; annual growth rate still north of 20%; cannot call this a deceleration story without ignoring the actual financial trajectory

→ vs conservative: Asking trader to fade a fresh bullish momentum signal (MACD crossover, RSI at 61, price closing above Bollinger upper band on highest volume day of recovery) in a name with record fundamentals is a position that requires more conviction than the data supports

→ vs conservative: Technical report recommends HOLD with bullish bias, not SELL; underweight at the precise moment when MACD, RSI, and Bollinger are all confirming bullish momentum is fighting the tape